Search Results - "Lever, R."

Refine Results
  1. 1

    Mast cell glycosaminoglycans by Mulloy, B., Lever, R., Page, C. P.

    Published in Glycoconjugate journal (01-06-2017)
    “…Mast cells contain granules packed with a mixture of proteins that are released on degranulation. The proteoglycan serglycin carries an array of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 by Nabarro, L.E.B., Lever, R.A., Armstrong, M., Chiodini, P.L.

    Published in Clinical microbiology and infection (01-08-2015)
    “…Giardia intestinalis is the commonest gastrointestinal protozoal pathogen worldwide, and causes acute and chronic diarrhoea with malabsorption. First-line…”
    Get full text
    Journal Article
  4. 4

    Efficacy and safety of low- versus high-dose glucocorticoid regimens for induction of remission of anti-neutrophil cytoplasm antibody-associated vasculitis: a systematic review and meta-analysis by Alchi, MB, Lever, R, Flossmann, O, Jayne, D

    Published in Scandinavian journal of rheumatology (03-09-2023)
    “…Glucocorticoids (GCs) remain a cornerstone of the initial management of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV), but have several…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax) by Lever, John R., Fergason-Cantrell, Emily A.

    Published in Pharmacological research (01-04-2019)
    “…[Display omitted] ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax) are under intensive preclinical and clinical investigation as treatments for…”
    Get full text
    Journal Article
  7. 7

    Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit by RAMPERSAUD, N, HARKAVYI, A, GIORDANO, G, LEVER, R, WHITTON, J, WHITTON, P. S

    Published in British journal of pharmacology (01-12-2012)
    “…BACKGROUND AND PURPOSE Parkinson's disease (PD) is characterized by progressive dopaminergic cell loss; however, the noradrenergic system exhibits degeneration…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Effect of structural modification in the amine portion of substituted aminobutyl-benzamides as ligands for binding σ1 and σ2 receptors by Fan, Kuo-Hsien, Lever, John R., Lever, Susan Z.

    Published in Bioorganic & medicinal chemistry (15-03-2011)
    “…A series of analogs, where the amine ring fused to the aromatic ring was varied in size (5–7) and the location of the nitrogen in this ring was modified, has…”
    Get full text
    Journal Article
  10. 10

    Hexamidine salts – applications in skin health and personal care products by Parisi, N., Matts, P. J., Lever, R., Hadgraft, J., Lane, M. E.

    Published in International journal of cosmetic science (01-08-2017)
    “…Hexamidine (HEX) has been used as a preservative in topical preparations since the 1950s. A number of studies also indicate that the molecule plays a…”
    Get full text
    Journal Article
  11. 11

    Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson’s disease with combined noradrenergic and serotonergic lesions by Rampersaud, N., Harkavyi, A., Giordano, G., Lever, R., Whitton, J., Whitton, P.S.

    Published in Neuropeptides (Edinburgh) (01-10-2012)
    “…Research on Parkinson’s disease (PD) has mainly focused on the degeneration of the dopaminergic neurons of nigro-striatal pathway; however, post-mortem studies…”
    Get full text
    Journal Article
  12. 12

    Glucocorticoid Clearance and Metabolite Profiling in an In Vitro Human Airway Epithelium Lung Model by Rivera-Burgos, Dinelia, Sarkar, Ujjal, Lever, Amanda R, Avram, Michael J, Coppeta, Jonathan R, Wishnok, John S, Borenstein, Jeffrey T, Tannenbaum, Steven R

    Published in Drug metabolism and disposition (01-02-2016)
    “…The emergence of microphysiologic epithelial lung models using human cells in a physiologically relevant microenvironment has the potential to be a powerful…”
    Get full text
    Journal Article
  13. 13

    The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine by Rodvelt, Kelli R, Oelrichs, Clark E, Blount, Lucas R, Fan, Kuo-Hsien, Lever, Susan Z, Lever, John R, Miller, Dennis K

    Published in Drug and alcohol dependence (01-07-2011)
    “…Abstract Background Methamphetamine's behavioral effects have been attributed to its interaction with monoamine transporters; however, methamphetamine also has…”
    Get full text
    Journal Article
  14. 14

    PET and SPECT imaging of the opioid system: receptors, radioligands and avenues for drug discovery and development by Lever, John R

    Published in Current pharmaceutical design (2007)
    “…As we celebrate the bicentennial of the isolation of morphine by Sertürner, opioids continue to dominate major sectors of the analgesic market worldwide. The…”
    Get more information
    Journal Article
  15. 15

    The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro by Jones, N.A., Boswell-Smith, V., Lever, R., Page, Clive P.

    Published in Pulmonary pharmacology & therapeutics (01-04-2005)
    “…Neutrophil-derived proteases such as neutrophil elastase (NE) and matrix metalloproteinase (MMP) are implicated in the pathogenesis of Chronic Obstructive…”
    Get full text
    Journal Article
  16. 16

    SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus by Rodvelt, Kelli R., Lever, Susan Z., Lever, John R., Blount, Lucas R., Fan, Kuo-Hsien, Miller, Dennis K.

    Published in Pharmacology, biochemistry and behavior (01-02-2011)
    “…Cocaine exhibits preferential (~ 15-fold) affinity for σ 1 over σ 2 sigma receptors, and previous research has shown an interaction of σ 1 receptor-selective…”
    Get full text
    Journal Article
  17. 17

    Narrowband ultraviolet B (UVB) phototherapy in children by Jury, C. S., McHenry, P., Burden, A. D., Lever, R., Bilsland, D.

    Published in Clinical and experimental dermatology (01-03-2006)
    “…Summary Background.  While narrowband ultraviolet B (UVB) phototherapy is a well‐established treatment for a range of skin conditions in adults, there is…”
    Get full text
    Journal Article
  18. 18

    Size‐fractionated heparins have differential effects on human neutrophil function in vitro by Lever, R, Lo, W T, Faraidoun, M, Amin, V, Brown, R A, Gallagher, J, Page, C P

    Published in British journal of pharmacology (01-07-2007)
    “…Background and purpose: Heparin is known to possess a range of activities, other than effects on blood coagulation, many of which are anti‐inflammatory…”
    Get full text
    Journal Article
  19. 19
  20. 20

    RETRACTED: Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson’s disease with combined noradrenergic and serotonergic lesions by Rampersaud, N, Harkavyi, A, Giordano, G, Lever, R, Whitton, J, Whitton, P.S

    Published in Neuropeptides (Edinburgh) (01-10-2012)
    “…This article has been retracted: please see Elsevier Policy on Article Withdrawal ( http://www.elsevier.com/locate/withdrawalpolicy ). This article has been…”
    Get full text
    Journal Article